Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004336:Drug Antagonism; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D005947:Glucose / Q000037:antagonists & inhibitors; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D010293:Pargyline / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010624:Phenelzine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012636:Secretory Rate / Q000187:drug effects; D014191:Tranylcypromine / Q000037:antagonists & inhibitors / Q000494:pharmacology
D001593:Benzyl Compounds; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D014191:Tranylcypromine; D012110:Reserpine; D010293:Pargyline; D005947:Glucose; D010624:Phenelzine; D004878:Ergotamine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine